Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Change in Inventory (2019 - 2025)

HealthLynked (HLYK) has disclosed Change in Inventory for 7 consecutive years, with $4388.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Inventory rose 124.92% to $4388.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$46842.0, a 26.16% increase, with the full-year FY2024 number at -$88536.0, down 48.52% from a year prior.
  • Change in Inventory was $4388.0 for Q3 2025 at HealthLynked, up from -$4670.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $28024.0 in Q4 2021 to a low of -$39775.0 in Q2 2024.
  • A 5-year average of -$4026.1 and a median of -$4670.0 in 2025 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: skyrocketed 2975.26% in 2024, then tumbled 516.59% in 2025.
  • HealthLynked's Change in Inventory stood at $28024.0 in 2021, then plummeted by 84.71% to $4286.0 in 2022, then crashed by 310.71% to -$9031.0 in 2023, then plummeted by 277.95% to -$34133.0 in 2024, then skyrocketed by 112.86% to $4388.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Change in Inventory are $4388.0 (Q3 2025), -$4670.0 (Q2 2025), and -$12427.0 (Q1 2025).